Randi B, Higashino H, Ponzio V, Abdala E, Guimaraes T, Vasques F
Bone Marrow Transplant. 2025; .
PMID: 39984749
DOI: 10.1038/s41409-025-02536-y.
Rodrigues N, Branco C, Sousa G, Silva M, Costa C, Marques F
Cancers (Basel). 2025; 17(3).
PMID: 39941904
PMC: 11816487.
DOI: 10.3390/cancers17030538.
Steiner N, Massoud R, Richter J, Perekhrestenko T, Gagelmann N, Niederwieser C
Eur J Haematol. 2024; 114(1):79-88.
PMID: 39300830
PMC: 11613535.
DOI: 10.1111/ejh.14305.
Gross S, Ihlow J, Busack L, Adamiak K, Schrezenmeier J, Jesse J
Blood Cancer J. 2024; 14(1):160.
PMID: 39284846
PMC: 11405931.
DOI: 10.1038/s41408-024-01140-5.
Steiner N, Baier K, Ritter D, Rudzki J, Hetzenauer G, Kock S
Ann Hematol. 2024; 103(11):4701-4705.
PMID: 39225777
PMC: 11534969.
DOI: 10.1007/s00277-024-05979-3.
Pediatric adapted risk index to predict 2-year transplant-related mortality post-HSCT in children.
Elfeky R, Builes N, Pearce R, Kania S, Nademi Z, Lucchini G
Blood Adv. 2024; 8(22):5838-5852.
PMID: 39093984
PMC: 11609366.
DOI: 10.1182/bloodadvances.2024013484.
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms.
Chalandon Y, Eikema D, Moiseev I, Ciceri F, Koster L, Vydra J
Blood Adv. 2024; 8(18):4792-4802.
PMID: 39008719
PMC: 11414667.
DOI: 10.1182/bloodadvances.2024013468.
Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M
Bone Marrow Transplant. 2024; 59(10):1402-1412.
PMID: 38987308
DOI: 10.1038/s41409-024-02361-9.
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.
Steiner N, Massoud R, Klyuchnikov E, Gagelmann N, Richter J, Niederwieser C
Bone Marrow Transplant. 2024; 59(9):1265-1274.
PMID: 38877098
PMC: 11368809.
DOI: 10.1038/s41409-024-02328-w.
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.
Robin M, Iacobelli S, Koster L, Passweg J, Avenoso D, Wilson K
Bone Marrow Transplant. 2024; 59(7):928-935.
PMID: 38491198
DOI: 10.1038/s41409-024-02269-4.
Adjusting diffusing capacity for anemia in patients undergoing allogeneic HCT: a comparison of two methodologies.
Yadav H, Hefazi Torghabeh M, Hoskote S, Pennington K, Lim K, Scanlon P
Curr Res Transl Med. 2024; 72(2):103432.
PMID: 38244276
PMC: 11102530.
DOI: 10.1016/j.retram.2023.103432.
Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study.
Baena J, Rosales M, Estacio M, Hidalgo A, Arrieta E, Jaramillo F
J Hematol. 2024; 12(6):255-267.
PMID: 38188474
PMC: 10769648.
DOI: 10.14740/jh1162.
Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study.
Rodrigues N, Costa C, Branco C, Martins C, Antonio Lopes J
J Nephrol. 2023; 37(2):419-428.
PMID: 38019417
PMC: 11043152.
DOI: 10.1007/s40620-023-01809-3.
Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic stem cell transplantation is associated with Leu432Val polymorphism.
Stute N, Koldehoff M
Haematologica. 2023; 109(3):799-808.
PMID: 37767566
PMC: 10905095.
DOI: 10.3324/haematol.2023.283649.
Endpoint selection and evaluation in hematology studies.
Brazauskas R, Eapen M, Wang T
Best Pract Res Clin Haematol. 2023; 36(3):101479.
PMID: 37611997
PMC: 10979628.
DOI: 10.1016/j.beha.2023.101479.
Predictive Risk Score for Acute Kidney Injury in Hematopoietic Stem Cell Transplant.
Rodrigues N, Fragao-Marques M, Costa C, Branco C, Marques F, Vasconcelos P
Cancers (Basel). 2023; 15(14).
PMID: 37509381
PMC: 10377961.
DOI: 10.3390/cancers15143720.
Automating outcome analysis after stem cell transplantation: The YORT tool.
von Asmuth E, Putter H, Mohseny A, Schilham M, Snowden J, Saccardi R
Bone Marrow Transplant. 2023; 58(9):1017-1023.
PMID: 37280431
DOI: 10.1038/s41409-023-02009-0.
Prognostic Significance of Early Declines in Pulmonary Function After Allogeneic Hematopoietic Stem Cell Transplantation.
Yadav H, Hefazi Torghabeh M, Hogan W, Limper A
Respir Care. 2023; 68(10):1406-1416.
PMID: 37253610
PMC: 10506643.
DOI: 10.4187/respcare.10925.
A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Jo T, Arai Y, Kanda J, Kondo T, Ikegame K, Uchida N
Commun Med (Lond). 2023; 3(1):67.
PMID: 37193882
PMC: 10188562.
DOI: 10.1038/s43856-023-00299-5.
Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation.
Zhao X, Wang W, Nie S, Geng L, Song K, Zhang X
Front Immunol. 2023; 14:1084901.
PMID: 37114055
PMC: 10126295.
DOI: 10.3389/fimmu.2023.1084901.